Tuesday, executives representing some of the nation’s most powerful pharmaceutical companies faced harsh scrutiny from members of the Senate Finance Committee – some of whom have received significant contributions from the industry.
LEARN MORE HERE – https://www.opensecrets.org/news/2019/02/senators-grill-big-pharma-executives/